Template:PDB Gallery/1432
Appearance
-
1a9u: The complex structure of the MAP kinase p38/SB203580
-
1bl6: The complex structure of the MAP kinase p38/SB216995
-
1bl7: The complex structure of the MAP kinase p38/SB220025
-
1bmk: The complex structure of the MAP kinase p38/SB218655
-
1di9: The structure of p38 mitogen-activated protein kinase in complex with 4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline
-
1ian: Human p38 MAP kinase inhibitor complex
-
1kv1: P38 MAP kinase in complex with inhibitor 1
-
1kv2: Human p38 MAP kinase in complex with BIRB 796
-
1lew: Crystal structure of MAP kinase p38 complexed to the docking site on its nuclear substrate mef2a
-
1lez: Crystal structure of MAP kinase p38 complexed to the docking site on its activatoR MKK3B
-
1m7q: Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor
-
1ouk: The structure of p38 alpha in complex with a pyridinylimidazole inhibitor
-
1ouy: The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor
-
1ove: The structure of p38 alpha in complex with a dihydroquinolinone
-
1oz1: P38 mitogen-activated kinase in complex with 4-azaindole inhibitor
-
1p38: The structure of the MAP kinase p38 at 2.1 angstroms resolution
-
1r39: The structure of p38alpha
-
1r3c: The structure of p38alpha C162S mutant
-
1w7h: P38 kinase crystal structure in complex with small molecule inhibitor
-
1w82: P38 kinase crystal structure in complex with small molecule inhibitor
-
1w83: P38 kinase crystal structure in complex with small molecule inhibitor
-
1w84: P38 kinase crystal structure in complex with small molecule inhibitor
-
1wbn: Fragment based p38 inhibitors
-
1wbo: Fragment based p38 inhibitors
-
1wbs: Identification of novel p38 alpha MAP kinase inhibitors using fragment-based lead generation
-
1wbt: Identification of novel p38 alpha MAP kinase inhibitors using fragment-based lead generation.
-
1wbv: Identification of novel p38 alpha MAP kinase inhibitors using fragment-based lead generation.
-
1wbw: Identification of novel p38 alpha MAP kinase inhibitors using fragment-based lead generation.
-
1wfc: Structure of APO, unphosphorylated, p38 mitogen activated protein kinase p38 (p38 MAP kinase) the mammalian homologue of the yeast HOG1 protein
-
1yqj: Crystal structure of p38 alpha in complex with a selective pyridazine inhibitor
-
1yw2: Mutated Mus musculus p38 kinase (mp38)
-
1ywr: Crystal structure analysis of inactive p38 kinase domain in complex with a monocyclic pyrazolone inhibitor
-
1zyj: Human p38 MAP kinase in complex with inhibitor 1a
-
1zz2: Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes
-
1zzl: Crystal structure of p38 with triazolopyridine
-
2baj: P38alpha bound to pyrazolourea
-
2bak: P38alpha MAP kinase bound to MPAQ
-
2bal: P38alpha MAP kinase bound to pyrazoloamine
-
2baq: P38alpha bound to Ro3201195
-
2ewa: Dual binding mode of pyridinylimidazole to MAP kinase p38
-
2fsl: Mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A
-
2fsm: Mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B
-
2fso: Mitogen activated protein kinase p38alpha (D176A) activating mutant
-
2fst: Mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant
-
2gfs: P38 Kinase Crystal Structure in complex with RO3201195
-
2ghl: Mutant Mus musculus p38 kinase domain in complex with inhibitor PG-874743
-
2ghm: Mutated MAP kinase p38 (Mus musculus) in complex with inhbitor PG-895449
-
2gtm: Mutated mouse p38 MAP kinase domain in complex with inhibitor PG-892579
-
2gtn: Mutated MAP kinase p38 (Mus musculus) in complex with inhbitor PG-951717
-
2i0h: The structure of p38alpha in complex with an arylpyridazinone
-
2okr: Crystal structure of the p38a-MAPKAP kinase 2 heterodimer
-
2onl: Crystal structure of the p38a-MAPKAP kinase 2 heterodimer
-
2oza: Structure of p38alpha complex